Our state-of-the-art laboratory is CLIA- and CAP-certified and staffed by a clinical leadership team with over 70 years of experience.
Talk to your doctor about newly-approved therapies that can delay the onset of type 1 diabetes.
Symptoms of type 1 diabetes can be misdiagnosed. Up to 12% of type 2 diabetes diagnoses may actually be type 1 diabetes.
Over 60,000 Americans of all ages get type 1 diabetes each year- a 30% increase since 2017. Over 88% of new cases have no family history of the disease.
We’ve published over 8 peer-reviewed and blinded studies of our type 1 diabetes assay, which is performed in our CLIA- and CAP-certified facility.
We work with all major insurance providers. We also offer affordable self-pay options for as little as $10.
Get actionable results from a finger-stick sample- no phlebotomy required.
Click the Sign-Up button and fill out the New Account Form
Meet with our team of onboarding specialists
Fill out the Test Requisition Form
Collect the sample and mail it to our CLIA- and CAP-certified facility
Receive test results with complimentary counseling and educational materials.
Enable will bill insurance or offer affordable self-pay options to the patient.
Type 1 diabetes is an autoimmune disorder, meaning that the body’s immune system mistakenly attacks and destroys its own healthy cells. In this instance, the specific cells being attacked are called beta cells, which are responsible for producing insulin in the pancreas. There is still a great deal of research to be done before we […]
What is the significance of autoantibodies in predicting type 1 diabetes? The presence of autoantibodies help determine the risk for type 1 diabetes. The presence and persistence of two or more autoantibodies defines Stage 1 type 1 diabetes and means that the individual has a >70% chance of advancing to Stage 2 type 1 diabetes […]
Autoantibodies in Type 1 Diabetes Have you or someone you know been diagnosed with type 1 diabetes? If so, then you may have heard of autoantibodies. Autoantibodies are proteins that the body produces when it mistakenly attacks its own tissues and organs. In the case of type 1 diabetes, autoantibodies can target the cells in […]